A new vaccine that primes the immune system to recognise and fight lung cancer is being tested for the first time on patients in the UK. Researchers leading the trial said the treatment could ...

It's simple to deliver, and you can select specific antigens in the cancer cell, and then you target them.' The phase one clinical trial is the first in human study of BNT116, which will be given ...